[1]
Burdette, B.; Esparza, A.; Zhu, H.; Wang, S. GsdmD in pyroptosis. Acta Pharm. Sin. B, 2021.
[2]
Zhang, D.; Burdette, B.E.; Wang, Z.; Karn, K.; Li, H.Y.; Schramm, V.L.; Tyler, P.C.; Evans, G.B.; Wang, S. Transition state analogues enhanced by fragment-based structural analysis: Bacterial methylthioadenosine nucleosidases. Biochemistry, 2020, 59, 831-835.
[3]
Wang, S.; Cameron, S.A.; Clinch, K.; Evans, G.B.; Wu, Z.; Schramm, V.L.; Tyler, P.C. New antibiotic candidates against Helicobacter pylori. J. Am. Chem. Soc., 2015, 137, 14275-14280.
[4]
Wei, L.; Chahwan, R.; Wang, S.; Wang, X.; Phuong, P.; Goodman, M.; Bergman, A.; Scharff, M.D.; MacCarthy, T. Overlapping hotspots in CDRs are critical sites for V region diversification. Proc. Natl. Acad. Sci. USA, 2015, 112, E728-E737.
[5]
Wang, S.; Haapalainen, A.M.; Yan, F.; Du, Q.; Tyler, P.C.; Evans, G.B.; Rinaldo-Matthis, A.; Brown, R.L.; Norris, G.E.; Almo, S.C.; Schramm, V.L. A picomolar transition state analogue inhibitor of MTAN as a specific antibiotic for Helicobacter pylori. Biochemistry, 2012, 51, 6892-6894.